Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gaucher Disease, Type I”

174 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 174 results

Post-approval studies (Phase 4)Study completedNCT00365131
What this trial is testing

Study of the Efficacy of Cerezyme in Testing Skeletal Disease in Patients With Type I Gaucher Disease.

Who this might be right for
Gaucher Disease Type ICerebroside Lipidosis SyndromeClucocerebrosidase Deficiency Disease+2 more
Genzyme, a Sanofi Company 40
Testing effectiveness (Phase 2)Ended earlyNCT03746587
What this trial is testing

Study of Arimoclomol in Patients Diagnosed With Gaucher Disease Type 1 or 3

Who this might be right for
Gaucher Disease, Type 1Gaucher Disease, Type 3
ZevraDenmark 39
Testing effectiveness (Phase 2)UnknownNCT00004293
What this trial is testing

Phase II Study of Glucocerebrosidase in Patients With Gaucher Disease

Who this might be right for
Gaucher's Disease
National Center for Research Resources (NCRR) 24
Not applicableStudy completedNCT01439607
What this trial is testing

Cellular and Molecular Mechanisms Governing Bone Marrow Stem Cells in Gaucher Disease

Who this might be right for
Gaucher Disease
Assistance Publique - Hôpitaux de Paris 30
Early research (Phase 1)Study completedNCT01427517
What this trial is testing

Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease

Who this might be right for
Parkinson's DiseaseGaucher's Disease
University of Minnesota 9
Not applicableUnknownNCT05816993
What this trial is testing

Assessment of Neurological Manifestations in Gaucher Disease Patients

Who this might be right for
Gaucher Disease
Assiut University 45
Not applicableStudy completedNCT04997772
What this trial is testing

Digital Health Platform Customized for Patients With Gaucher Disease

Who this might be right for
Gaucher DiseasePatient Reported Outcome
Shoshana Vilk 80
Testing effectiveness (Phase 2)Study completedNCT00391625
What this trial is testing

Open-Label Extension Study Evaluating Long Term Safety in Patients With Type 1 Gaucher Disease Receiving DRX008A (ERT)

Who this might be right for
Gaucher Disease
Shire 10
Testing effectiveness (Phase 2)UnknownNCT05447494
What this trial is testing

Phase 1/2 Study of CAN103 in Subjects With Gaucher Disease

Who this might be right for
Gaucher Disease, Type 1Gaucher Disease, Type 3
CANbridge (Suzhou) Bio-pharma Co., Ltd. 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06545136
What this trial is testing

Long Term Follow-up Study of Type-1 Gaucher Subjects Post FLT201 Dose (GALILEO-2)

Who this might be right for
Gaucher Disease, Type 1
Spur Therapeutics 75
Not applicableActive Not RecruitingNCT06488261
What this trial is testing

Long Term Follow-Up for Safety of AVR-RD-02

Who this might be right for
Gaucher Disease
John Bernat 2
Testing effectiveness (Phase 2)Study completedNCT02583672
What this trial is testing

Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1)

Who this might be right for
Gaucher Disease Type 1
University of Minnesota 33
Very early researchActive Not RecruitingNCT06528080
What this trial is testing

A Clinical Study for the Treatment of Pediatric and Adolescent Patients With Type 1 Gaucher Disease

Who this might be right for
Gaucher Disease
Shanghai Jiao Tong University School of Medicine 3
Not applicableStudy completedNCT04470713
What this trial is testing

Natural History Study for Pediatric Patients With Early Onset of Either GM1 Gangliosidosis, GM2 Gangliosidoses, or Gaucher Disease Type 2

Who this might be right for
GM1 GangliosidosisGM2 GangliosidosisGaucher Disease, Type 2+3 more
Idorsia Pharmaceuticals Ltd. 226
Testing effectiveness (Phase 2)Looking for participantsNCT06818838
What this trial is testing

A Clinical Study Evaluating LY-M001 Injection in the Treatment of Adult Patients With Type I Gaucher Disease

Who this might be right for
Gaucher Disease Type 1
Lingyi Biotech Co., Ltd. 12
Post-approval studies (Phase 4)Study completedNCT04002830
What this trial is testing

A Multicenter, Safety and Efficacy Study of Taliglucerase Alfa in Subjects With Type 3 Gaucher Disease

Who this might be right for
Gaucher Disease, Type 3
Ari Zimran 14
Not applicableUnknownNCT02605603
What this trial is testing

SRT in Comparison to ERT on Immune Aspects and Bone Involvement in Gaucher Disease

Who this might be right for
Gaucher Disease
Lysosomal and Rare Disorders Research and Treatment Center, Inc. 30
Not applicableUnknownNCT05536388
What this trial is testing

Drug Discovery for Parkinson's With Mutations in the GBA Gene

Who this might be right for
Parkinson DiseaseGaucher DiseaseHealthy+1 more
New York Stem Cell Foundation Research Institute 60
Not applicableStudy completedNCT01358474
What this trial is testing

Detecting Dopaminergic Deficits in Individuals At-risk for Parkinsonism

Who this might be right for
Parkinson DiseaseGaucher DiseaseIdiopathic Rapid Eye Movement Sleep Disorder
University of Minnesota 56
Large-scale testing (Phase 3)Study completedNCT00319046
What this trial is testing

Clinical Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Miglustat in Patients With Stable Type 1 Gaucher Disease

Who this might be right for
Gaucher Disease Type 1
Actelion 42
Next Page